A 2-Day Overlap of Bupropion 150 mg with Sertraline During Medication Switch is Generally Safe
A brief overlap of bupropion 150 mg daily with sertraline for 2 days during a medication switch is acceptable and carries minimal risk, though close monitoring is warranted. The primary concern is the theoretical risk of serotonin syndrome, but at this low dose and short duration, the risk is very low.
Key Safety Considerations
Drug Interaction Profile
The FDA label for bupropion indicates that it inhibits CYP2D6, which can increase concentrations of sertraline 1. However, sertraline is noted to have less effect on metabolism of other medications compared to other SSRIs 2. The interaction works both ways: sertraline can also affect bupropion metabolism through CYP2B6 inhibition, though animal studies show this may actually slightly increase bupropion metabolism rather than decrease it 3.
Serotonin Syndrome Risk
While there is one case report of serotonin syndrome occurring with the combination of bupropion and sertraline 4, this occurred after 3 weeks of combined therapy at therapeutic doses, not during a brief 2-day overlap. The patient in that case also had venlafaxine added, complicating the picture. The risk during a 2-day overlap at 150 mg bupropion daily is substantially lower than with prolonged combination therapy.
The 2020 AACAP guidelines note that caution with serotonergic drug combinations "entails starting the second non-MAOI serotonergic drug at a low dose, increasing the dose slowly, and monitoring for symptoms, especially in the first 24 to 48 hours after dosage changes" 5. Your 2-day overlap falls within this monitoring window.
Evidence Supporting Brief Overlap Safety
Multiple studies demonstrate that bupropion and sertraline can be safely combined:
- Clinical case series showed 70% of patients improved with combined bupropion-sertraline therapy without seizures, though sexual dysfunction (41%), insomnia (22%), and tremor (11%) occurred 6
- A study of treatment-refractory patients found the combination effective with no adverse effects reported 7
- The combination is used therapeutically for augmentation strategies in depression 8
Practical Switching Approach
For your specific 2-day overlap:
- Continue sertraline at current dose
- Start bupropion 150 mg daily (this is the appropriate starting dose per NCCN guidelines 9)
- Monitor closely for 48 hours for signs of serotonin syndrome:
- Mental status changes (agitation, confusion)
- Autonomic instability (tachycardia, blood pressure changes, sweating)
- Neuromuscular abnormalities (tremor, rigidity, myoclonus, hyperreflexia)
- After 2 days, discontinue sertraline completely
Important Caveats
Contraindications to this approach:
- History of seizures or conditions that lower seizure threshold (bupropion is contraindicated) 9
- Brain metastases (absolute contraindication for bupropion) 9
- Current use of MAOIs (requires 2-week washout) 10
- Taking tamoxifen (bupropion contraindicated) 9
The maximum recommended bupropion dose is 300 mg/day 9, so your 150 mg starting dose provides a safety margin.
Alternative Conservative Approach
If you prefer maximum caution, the FDA label for sertraline states: "Do not start sertraline if you stopped taking an MAOI in the last 2 weeks unless directed to do so by your physician" 10. While this specifically addresses MAOIs, conservative switching strategies involve "gradually tapering the first antidepressant followed by an adequate washout period" 11. However, this approach risks a treatment gap and potential symptom exacerbation.
The 2-day overlap represents a reasonable middle ground between overly conservative approaches that leave patients untreated and aggressive cross-tapering that increases drug interaction risks. Given sertraline's relatively short half-life compared to fluoxetine 5, a 2-day overlap provides continuity of treatment while minimizing accumulation risk.